Lumenis recently showcased its approach to gynecology and its innovative CO2 laser technology for endometriosis at the American Association of Gynecologic Laparoscopists (AAGL) Annual Meeting Nov. 14-18 in Orlando, Florida.
The company also presented its recently launched website created to raise awareness for endometriosis and to encourage patients to seek medical care.
In endometriosis, tissue that normally lines the uterus, called the endometrium, grows outside the uterus. It is one of the most common gynecological diseases, causing symptoms such as bleeding, pain and infertility. The cause of endometriosis remains unknown, and while prevalence rates increase, the disease is still often misdiagnosed, with women suffering with years of pain and infertility before they get a correct diagnosis and treatment.
Although there is currently no cure for the disease, Lumenis technologies are earning respect from leading endometriosis surgeons. These instruments are capable of operating with unique precision around delicate anatomy with minimal thermal damage while preserving healthy tissue. The procedure to remove endrometriosis lesions results in less time needed to heal from surgery and lower recurrence rates. Fertility preservation rates may also be improved after the CO2 laser treatment.
Lumenis’ CO2 laser energy, delivered through the FiberLase CO2 laser fiber, is accurate and versatile. The fibers enable surgeons to easily access difficult-to-reach anatomy through handpieces or a flexible endoscope with a renewable tip, allowing precise procedures to be performed quickly. FiberLase can be used through the side port or through the laparoscope, or with flexible scopes and robotic-assisted surgery.
“Of the various lasers available, the CO2 laser is the most versatile and is extremely safe because of its limited depth of penetration and minimal lateral thermal damage,” Dr. Ceana Nezhat of the Atlanta Center for Special Minimally Invasive Surgery & Reproductive Medicine, said in a press release.
“This allows for use of the CO2 laser in delicate areas where electrosurgery would be unsafe, such as the bladder, lateral side wall near the ureter, nerves, major vessels, and bowel serosa,” Nezhat said.
“In endometriosis patients, clinical data has demonstrated good pain control, improved quality of life, peri-operative outcome, and fertility rates with use of the CO2 laser,” she added. “The FiberLase flexible CO2 fiber is intuitive and easy to use, and has overcome the blooming effect and other challenges associated with the older generation of CO2 lasers. The Lumenis CO2 laser is a valuable instrument in the armamentarium of the gynecology surgeon.”
Lumenis also presented its new website, created to raise awareness and educate patients about endometriosis, at the AAGL meeting. Through the site, the company provides valuable and useful resources for patients and encourages them to take charge of their lives and get the appropriate treatment.
For more information, visit www.gynhealth.com.